The circBART2.2 is correlated both with the inhibition of T-cell function and the upregulation of the programmed cell death-ligand 1, which belong to a signalling pathway mediating tumour immunosuppression, thus, favouring the carcinoma proliferation. The gene discussed is CD274; the disease is carcinoma.